奧朗生物醫藥有限公司

Research Associate (Gene Therapy)

奧朗生物醫藥有限公司
Posted on 9-Apr-21

Research Associate (Gene Therapy)

奧朗生物醫藥有限公司

Job Highlights

  • Permanent Job
  • Attractive remuneration and benefits
  • Fresh graduates welcomed

Job Description

The Job:

  • Provide support for gene delivery platform.
  • Provide support for optimization gene delivery process.
  • To prepare the SOP documents.
  • Perform Ad-hoc task assigned by supervisor.

The Person:

  • BSc/ Master in Biology, Cell Biology, Biotechnology or relevant discipline.
  • 1-2 years of working experience in protein field, fresh graduates are welcomed.
  • Experience with cell culture (adherent/ suspension), transfection of mRNA, DNA, siRNA; familiar with agarose gel electrophoresis.
  • Work experience with Fluorescent microscope, flow cytometry, confocal microscope.
  • Have good time management and organization skills with ability to function independently, with little supervision.
  • Able to follow SOPs to perform assigned task.
  • Independent and enthusiastic, with good communication skills and team spirit.
  • Have good analytical and problem-solving skills.
  • Proficiency in spoken and written English and Chinese.
  • Travelling to PRC and overseas as well as stationing for a short period may be required.

We offer competitive remuneration package and excellent career prospects to qualified candidates. Interested parties please send your CV together with present and expected salaries with contact details to the Human Resources Manager by clicking apply now.

Applicants who are not contacted by email or call within 1 month may consider their application is unsuccessful and the personal data collected will be destroyed in due course.

Additional Information

Career Level
Entry Level
Qualification
Degree
Years of Experience
1 year
Job Type
Full Time, Permanent

Company Overview

Alephoson Biopharmaceuticals Limited (AB) is a private, technology-based company focusing on research and development of innovative drug delivery technologies to fulfil unmet medical needs. By utilizing the destructive, and proprietary next generation Cell Penetration Protein Alternation Technology (CePPA), we are working to overcome the limitations of current treatments for serious ophthalmic diseases by developing a topical eye drop alternative to intravitreal (back-of-the eye) injection therapies. At AB, we understand the critical role vision plays in a patient’s quality of life, and we know the frustration that ophthalmologists face when they are unable to treat their patients successfully, and for patients and families for whom the burden of chronic treatment can be overwhelming. We are determined to develop new ocular therapies that help patients see their very best throughout their lives. Our management team and board of directors bring extensive experience discovering, evaluating, developing, and commercializing drugs. These novel therapies may include improvements to existing medicines or entirely new molecules.

Additional Company Information

Industry
Medical/Pharmaceutical
Benefits & Others
Medical insurance, Five-day work week